Long-term Tolerability

Long-Term Tolerability is the sustained capacity of a pharmacotherapeutic agent to be safely and acceptably used over an extended period in the management of Allergic Rhinitis, characterized by the absence of clinically significant adverse effects and maintenance of patient adherence.

220

Publications

12.9K

Citations

1.5K

Authors

726

Institutions

Publications per year

2017–2026

48

Authors

1.5K

  1. JA
    John A. Messenheimer

    University of North Carolina at Chapel Hill, United States

    4 publications · 102 citations

    4

    h-index

  2. NH
    Nobuya Hayashi

    AstraZeneca (Japan), Japan

    2 publications · 63 citations

    2

    h-index

  3. SG
    Sebastian Grosicki

    Medical University of Silesia, Poland

    2 publications · 183 citations

    2

    h-index

  4. AV
    Antonio Valero

    University of Córdoba, Spain

    2 publications · 48 citations

    2

    h-index

  5. JS
    J Sany

    Hôpital Lapeyronie, France

    2 publications · 28 citations

    2

    h-index

1–5 of 1.5K

Venues

  1. PubMed

    Repository · 18 publications · 524 citations

    14

    h-index

  2. Annals of Allergy Asthma & Immunology

    ACAAI · 8 publications · 256 citations

    8

    h-index

  3. Journal of Clinical Oncology

    7 publications · 842 citations

    7

    h-index

  4. Clinical Therapeutics

    6 publications · 263 citations

    6

    h-index

  5. Journal of Allergy and Clinical Immunology

    4 publications · 358 citations

    4

    h-index

1–5